Functional inactivation of Plasmodium falciparum glycogen synthase kinase GSK3 modulates erythrocyte invasion and blocks gametocyte maturation.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
09 2022
Historique:
received: 02 05 2022
revised: 28 07 2022
accepted: 29 07 2022
pubmed: 13 8 2022
medline: 30 9 2022
entrez: 12 8 2022
Statut: ppublish

Résumé

Malaria is responsible for hundreds of thousands of deaths every year. The lack of an effective vaccine and the global spread of multidrug resistant parasites hampers the fight against the disease and underlines the need for new antimalarial drugs. Central to the pathogenesis of malaria is the proliferation of Plasmodium parasites within human erythrocytes. Parasites invade erythrocytes via a coordinated sequence of receptor-ligand interactions between the parasite and the host cell. Posttranslational modifications such as protein phosphorylation are known to be key regulators in this process and are mediated by protein kinases. For several parasite kinases, including the Plasmodium falciparum glycogen synthase kinase 3 (PfGSK3), inhibitors have been shown to block erythrocyte invasion. Here, we provide an assessment of PfGSK3 function by reverse genetics. Using targeted gene disruption, we show the active gene copy, PfGSK3β, is not essential for asexual blood stage proliferation, although it modulates efficient erythrocyte invasion. We found functional inactivation leads to a 69% decreased growth rate and confirmed this growth defect by rescue experiments with wildtype and catalytically inactive mutants. Functional knockout of PfGSK3β does not lead to transcriptional upregulation of the second copy of PfGSK3. We further analyze expression, localization, and function of PfGSK3β during gametocytogenesis using a parasite line allowing conditional induction of sexual commitment. We demonstrate PfGSK3β-deficient gametocytes show a strikingly malformed morphology leading to the death of parasites in later stages of gametocyte development. Taken together, these findings are important for our understanding and the development of PfGSK3 as an antimalarial target.

Identifiants

pubmed: 35961464
pii: S0021-9258(22)00803-1
doi: 10.1016/j.jbc.2022.102360
pmc: PMC9478393
pii:
doi:

Substances chimiques

Antimalarials 0
Ligands 0
Protozoan Proteins 0
Glycogen Synthase Kinase 3 EC 2.7.11.26

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102360

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Arne Alder (A)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany.

Louisa Wilcke (L)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany.

Emma Pietsch (E)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany.

Heidrun von Thien (H)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany.

Samuel Pazicky (S)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Hamburg Unit, European Molecular Biology Laboratory, Hamburg, Germany.

Christian Löw (C)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Hamburg Unit, European Molecular Biology Laboratory, Hamburg, Germany.

Paolo Mesen-Ramirez (P)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany.

Anna Bachmann (A)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany.

Paul-Christian Burda (PC)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany.

Conrad Kunick (C)

Institut für Medizinische und Pharmazeutische Chemie, Technische Universität Braunschweig, Braunschweig, Germany.

Holger Sondermann (H)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Deutsches Elektronen-Synchrotron DESY, Germany; Christian-Albrechts-Universität zu Kiel, Kiel, Germany.

Danny Wilson (D)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, South Australia, Australia; Burnet Institute, Melbourne, Victoria, Australia; Institute for Photonics and Advanced Sensing (IPAS), University of Adelaide, South Australia, Australia.

Tim-Wolf Gilberger (TW)

CSSB Centre for Structural Systems Biology, Hamburg, Germany; Department of Cellular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Department of Biology, University of Hamburg, Hamburg, Germany. Electronic address: gilberger@bnitm.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH